Results 1 to 10 of about 314,711 (252)
Ca-A Cancer Journal for Clinicians, 1982 The clinical presentation of renal cell carcinoma is often diverse and outcome is notoriously difficult to predict. The only therapy for renal cell carcinoma with curative potential is radical surgery for patients presenting with locoregional disease.
George W Jones
exaly +5 more sources
Simultaneous Chromophobe renal cell carcinoma and squamous renal cell carcinoma [PDF]
Diagnostic Pathology, 2007 Chromophobe renal cell carcinoma (CHRC) is a neoplasm of the kidney with clinicopathologic peculiarities that seems to be of better prognosis than conventional renal cell carcinoma.
Robles Luis +4 more
doaj +3 more sources
Nature Reviews Disease Primers, 2017 Renal cell carcinoma (RCC) denotes cancer originated from the renal epithelium and accounts for >90% of cancers in the kidney. The disease encompasses >10 histological and molecular subtypes, of which clear cell RCC (ccRCC) is most common and accounts for most cancer-related deaths. Although somatic VHL mutations have been described for some time, more-
James J Hsieh +2 more
exaly +5 more sources
New trends and future prospects of regulatory cell death in renal carcinoma [PDF]
Zhongguo aizheng zazhi, 2022 Renal cell carcinoma is one of the most common malignancies in genitourinary cancers. In China, the incidence of renal cell carcinoma has been increasing year by year.
CAO Dalong, YE Dingwei
doaj +3 more sources
Thyroid-like Follicular Carcinoma of the Right Kidney: A Case Report [PDF]
Middle East Journal of Cancer, 2019 Renal cell carcinoma is responsible for approximately 80% of malignant tumors of the kidney. Clear cell, papillary, and chromophobe forms comprise the most frequent histological subtypes of renal cell carcinoma.
Mohammad Hossein Sanei +4 more
doaj +2 more sources
Sohlh2 Inhibits the Malignant Progression of Renal Cell Carcinoma by Upregulating Klotho via DNMT3a
Frontiers in Oncology, 2022 BackgroundRenal cell carcinoma is the most common malignant tumor of the kidney. The 5-year survival of renal cell carcinoma with distant metastasis is very low.
Yang Liu +10 more
doaj +1 more source
World Journal of Urology, 2016 Renal cell cancer (RCC) accounts for approximately 2–3 % of all human malignancies and shows a worldwide increase of incidence rate of 2 % per year [1]. It primarily affects men and women at the age of 50–70 years with a twofold higher incidence rate in men.
Axel S, Merseburger +2 more
openaire +2 more sources
Metastatic Renal Cell Carcinoma to Duodenum and Pancreas 10 Years After Nephrectomy: A Case Report
Case Reports in Clinical Practice, 2023 Renal cell carcinoma (RCC) accounts for 2-3% of the malignant tumors in adult patients. The most common sites of metastasis are the lung, bone, liver and brain respectively.
Mahsa Akbari Oryani +3 more
doaj +1 more source
Journal of Medical Case Reports, 2021 Background Metastatic spread to the pancreas is a rare event. Renal cell carcinoma represents one possible site of origin of pancreatic metastases. Renal cell carcinoma often metastasizes late and exclusively to the pancreas, suggesting a special role of
Lena Haeberle +6 more
doaj +1 more source
Unusual head and neck presentation of metastatic renal cell carcinoma
Otolaryngology Case Reports, 2023 Skull base metastasis from renal cell carcinoma are exceedingly rare. Though renal cell carcinoma often presents at an advanced stage and with metastasis, signs and symptoms of skull base involvement would rarely suggest renal cell carcinoma.
Kyle J. Kozak +2 more
doaj +1 more source